heart-attackThe Alliance for the Advancement of  Adult Stem Cell Therapy and Research Announces,a non-profit organization dedicated to promoting the use of adult stem cells in the research and treatment of life-altering diseases, claims that as per six months observation of a clinical study, it is found that stem cell therapy can shows impressive results that improve cardiac function and quality of life.

The clinical study is a collaborative effort among physicians at Regenocyte Therapeutic, an American stem cell therapy clinic; researchers and scientists from Theravitae, a biotechnology company from Israel; and physicians from the American Institute for Regenerative Medicine, Dominican Republic.

According to Zannos Grekos, MD, Associate Clinical Professor at Nova Southeastern University, a six month follow-up results for the patient treated with adult stem cells in a clinical study of idiopathic dilated cardiomyopathy shows amazing results.

Grekos further added that the difference between the before and after treatment echocardiogram and MUGA nuclear scans of the patient confirms a profound improvement in cardiac functions.

Seventy-one years old Leonard Narracci, from Venice, Florida, who was diagnosed with idiopathic dilated cardiomyopathy and congestive heart failure, and due to the ailing condition his ejection fraction was severely reduced at 18% (with normal being over 55%). Within three months of stem cell therapy his ejection fraction improved to 40% and it is now at 51%.

Dr. Leonel Fernandez Liriano, Professor of Medicine at Pontifical Catholic University School of Medicine (PCUSM), and the head of the cardiology team that treated the patient with adult stem cells, believes that besides trying to fix damaged heart muscle it is better to generate  new heart tissues through stem cell therapy, which is showing  impressive results and can improve cardiac function along with quality of life substantially.

Regenocyte Therapeutic claimed that they had treated several similar patients with a continuing rate of improvement.

They have had success in the ischemic heart disease patients since 2006, and it is encouraging to see that their stem cell technology can now be successfully applied to other diseases for example,  pulmonary hypertension, COPD, kidney disease, peripheral artery disease, and early senile dementia.

For further details about The Alliance for the Advancement of Adult Stem Cell Therapy and Research, you may call them at  (239) 498-9187. or e-mail at GFinley@Regenocyte.com .

Source: Business Wire